Daehwajeayak Acquires Patent Rights for Syrup and Powder Formulation Technologies
[Asia Economy Reporter Ji Yeon-jin] Daehwa Pharmaceutical announced on the 4th that it has obtained a patent for an oral pharmaceutical composition in the form of a syrup or powder formulation containing water-soluble active pharmaceutical ingredients.
Hot Picks Today
"Samsung Electronics Eyes Special Dividend of Up to 125 Trillion Won"...Foreign Investors Shift from Common to Preferred Shares
- When SK hynix Rose 1,200%, This Stock Soared 1,800%... Headed for 1.85 Million Won [Click e-Stock]
- Nowhere Is Safe, Not Even Walkways or Restrooms... Japan Trembles Amid Growing 'Bear Fear' in Daily Life
- "What About Those Who Paid 220,000 Won?"... Chinese Maotai Faces Major Setback and Plummeting Prices
This patent relates to a technology that formulates zanamivir inhalation into a syrup form to increase ease of administration, combining the advantages of syrup form with the convenience of storage and distribution while preventing moisture changes in the powder formulation.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
